Nan-Haw Chow
Overview
Explore the profile of Nan-Haw Chow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Y, Chu C, Wang J, Chen W, Wang Y, Ho C, et al.
Cytokine Growth Factor Rev
. 2025 Jan;
81:9-15.
PMID: 39794156
Receptor tyrosine kinases (RTKs) are membrane sensors that monitor alterations in the extracellular milieu and translate this information into appropriate cellular responses. Epidermal growth factor receptor (EGFR) is the most...
2.
Wang Y, Tuan Y, Wang J, Chang H, Chu C, Chen Y, et al.
Oncol Rep
. 2024 Nov;
53(1).
PMID: 39611484
Amplification of human epidermal growth factor 2 receptor (HER2) and overexpression of estrogen receptor (ER) and/or progesterone receptor (PR) are key determinants in the treatment planning for human breast cancer...
3.
Liu T, Ho C, Chen Y, Chen P, Chen W, Lee C, et al.
Oncol Lett
. 2024 Aug;
28(3):445.
PMID: 39099584
Microsatellite instability (MSI) status is a prognostic biomarker for immunotherapy in certain types of cancers, such as colorectal cancers (CRCs) and endometrial cancers (ECs). Tumors that are categorized as having...
4.
Chang C, Chen Y, Wang Y, Chen H, Hsu C, Lin K, et al.
Oncol Rep
. 2024 Jan;
51(3).
PMID: 38240107
Various types of human cancer may develop aberrant trophoblastic differentiation, including histological changes and altered expression of β‑human chorionic gonadotropin (β‑hCG). Aberrant trophoblastic differentiation in epithelial cancer is usually associated...
5.
Chen Y, Lin C, Yu Y, Chen W, Yang S, Huang W, et al.
Oncol Lett
. 2023 Nov;
26(6):539.
PMID: 38020305
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the first-line regimen for the treatment of non-small cell lung cancer (NSCLC) patients with EGFR mutations. However, false-negative results are occasionally...
6.
Hsiao K, Ruan S, Chen S, Lai T, Chan R, Zhang Y, et al.
Cell Commun Signal
. 2023 Jul;
21(1):172.
PMID: 37430297
Background: Protein phosphatase 2A (PP2A) is one of the major protein phosphatases in eukaryotic cells and is essential for cellular homeostasis. PP2A is a heterotrimer comprising the dimeric AC core...
7.
Chou L, Hsu C, Yang S, Lee C, Ou Y, Lin K, et al.
Clin Genitourin Cancer
. 2023 May;
21(4):508.e1-508.e10.
PMID: 37183125
Introduction/Background To determine the clinical significance of micropapillary urothelial carcinoma (MPUC) of the upper urinary tract (UTUC) and a potential therapeutic strategy. Patients and Methods A retrospective cohort study was...
8.
Huang W, Ho C, Lee C, Chen W, Yang S, Chow N, et al.
PLoS One
. 2023 Apr;
18(4):e0284227.
PMID: 37098015
Microsatellite instability (MSI) is the primary predictive biomarker for therapeutic efficacies of cancer immunotherapies. Establishment of the MSI detection methods with high sensitivity and accessibility is important. Because MSI is...
9.
Lee C, Chu C, Wang Y, Wang Y, Chen Y, Ho C, et al.
Mol Carcinog
. 2023 Apr;
62(7):951-962.
PMID: 37014154
Sprouty2 (SPRY2) is known to inhibit the RAS/MAPK/ERK pathway, and is a potential study target for cancer. The effect of SPRY2 in colorectal cancer (CRC) and whether it is influenced...
10.
Chen Y, Ho C, Hung C, Chen W, Chang C, Hou Y, et al.
Front Oncol
. 2022 Dec;
12:1014132.
PMID: 36568146
Clonality assessment, which can detect neoplastic T cells by identifying the uniquely recombined T-cell receptor (TCR) genes, provides important support in the diagnosis of T-cell lymphoma (TCL). BIOMED-2 is the...